Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 7,500 shares at $19.19 ($144K) on 2020-03-16, disclosed to the SEC on 2020-03-18.
Open-market sale of $144k ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.19 | 3,750 | $72K | 50.0% |
| 2 | $19.19 | 3,750 | $72K | 50.0% |
| Total | $19.19 avg | 7,500 | $144K | 100% |
| Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |
| ALLO | SELL | 2020-10-13 | $1.5M | — | Filing → |